Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Citeline’s Third Party Access (TPA) program streamlines the process for existing Clients to request an agreement for a Third-Party Vendor to perform services for that Client. Third Party Access licenses are usually for limited use only.
TPAs enable Citeline Clients to share Citeline data, content and information with Vendors for a pre-defined purpose and are available exclusively for the support of the requesting Citeline client. This program has been designed to make Third-Party Access as quick and seamless as possible for Clients (and their projects).
Third Parties may not use the Citeline data made available under any TPA for their own purposes or benefit. Citeline Clients must have active, enterprise licenses to the Citeline products they wish to have their Third-Party Vendor use.
The vast majority of TPAs are approved, though Citeline reserves the right to reject applications at its discretion.
Clients should not share any licensed Citeline data, information, excerpts, outputs, reports or any other Intellectual Property with Third-Party Vendors until applications have been formally approved and the relevant Agreements are signed by all parties.
Vendors are not permitted to initiate TPA applications, these must come from the Client company.
Clients can obtain a TPA ID and check on the TPA Application status by contacting their Citeline account representative. Start the process today by completing the questionnaire below.
Contact us at:email@example.com
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: